BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. Common Stock BTSG Peers
See (BTSG) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BTSG | $23.67 | -1.09% | 4.1B | 87.67 | $0.27 | N/A |
| VEEV | $284.79 | +2.21% | 46.4B | 60.59 | $4.70 | N/A |
| GEHC | $71.14 | +1.41% | 32.6B | 14.95 | $4.76 | +0.18% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | +0.18% |
| DOCS | $53.51 | +3.89% | 10B | 48.20 | $1.11 | N/A |
| HQY | $103.71 | +0.88% | 9B | 95.15 | $1.09 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| BTSGU | $82.54 | -1.33% | 4.1B | N/A | N/A | N/A |
| ONEM | $16.47 | N/A | 3.4B | -7.77 | -$2.12 | N/A |
Stock Comparison
BTSG vs VEEV Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, VEEV has a market cap of 46.4B. Regarding current trading prices, BTSG is priced at $23.67, while VEEV trades at $284.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas VEEV's P/E ratio is 60.59. In terms of profitability, BTSG's ROE is +0.03%, compared to VEEV's ROE of +0.14%. Regarding short-term risk, BTSG is less volatile compared to VEEV. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs GEHC Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, GEHC has a market cap of 32.6B. Regarding current trading prices, BTSG is priced at $23.67, while GEHC trades at $71.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas GEHC's P/E ratio is 14.95. In terms of profitability, BTSG's ROE is +0.03%, compared to GEHC's ROE of +0.26%. Regarding short-term risk, BTSG is less volatile compared to GEHC. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs GEHCV Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, BTSG is priced at $23.67, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas GEHCV's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to GEHCV's ROE of +0.26%. Regarding short-term risk, BTSG is less volatile compared to GEHCV. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs DOCS Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, DOCS has a market cap of 10B. Regarding current trading prices, BTSG is priced at $23.67, while DOCS trades at $53.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas DOCS's P/E ratio is 48.20. In terms of profitability, BTSG's ROE is +0.03%, compared to DOCS's ROE of +0.22%. Regarding short-term risk, BTSG is less volatile compared to DOCS. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs HQY Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, HQY has a market cap of 9B. Regarding current trading prices, BTSG is priced at $23.67, while HQY trades at $103.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas HQY's P/E ratio is 95.15. In terms of profitability, BTSG's ROE is +0.03%, compared to HQY's ROE of +0.05%. Regarding short-term risk, BTSG is less volatile compared to HQY. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs SGFY Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, BTSG is priced at $23.67, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SGFY's P/E ratio is 70.91. In terms of profitability, BTSG's ROE is +0.03%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, BTSG is more volatile compared to SGFY. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs RCM Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, BTSG is priced at $23.67, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas RCM's P/E ratio is -102.21. In terms of profitability, BTSG's ROE is +0.03%, compared to RCM's ROE of -0.02%. Regarding short-term risk, BTSG is more volatile compared to RCM. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs BTSGU Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, BTSGU has a market cap of 4.1B. Regarding current trading prices, BTSG is priced at $23.67, while BTSGU trades at $82.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas BTSGU's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to BTSGU's ROE of +0.03%. Regarding short-term risk, BTSG is more volatile compared to BTSGU. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs ONEM Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, BTSG is priced at $23.67, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas ONEM's P/E ratio is -7.77. In terms of profitability, BTSG's ROE is +0.03%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, BTSG is less volatile compared to ONEM. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs PRVA Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, PRVA has a market cap of 2.8B. Regarding current trading prices, BTSG is priced at $23.67, while PRVA trades at $22.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas PRVA's P/E ratio is 191.42. In terms of profitability, BTSG's ROE is +0.03%, compared to PRVA's ROE of +0.02%. Regarding short-term risk, BTSG is more volatile compared to PRVA. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs WGS Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, WGS has a market cap of 2.1B. Regarding current trading prices, BTSG is priced at $23.67, while WGS trades at $72.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas WGS's P/E ratio is -52.38. In terms of profitability, BTSG's ROE is +0.03%, compared to WGS's ROE of -0.17%. Regarding short-term risk, BTSG is less volatile compared to WGS. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs PINC Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, PINC has a market cap of 1.9B. Regarding current trading prices, BTSG is priced at $23.67, while PINC trades at $23.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas PINC's P/E ratio is 22.61. In terms of profitability, BTSG's ROE is +0.03%, compared to PINC's ROE of +0.03%. Regarding short-term risk, BTSG is more volatile compared to PINC. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs PGNY Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, PGNY has a market cap of 1.9B. Regarding current trading prices, BTSG is priced at $23.67, while PGNY trades at $21.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas PGNY's P/E ratio is 38.56. In terms of profitability, BTSG's ROE is +0.03%, compared to PGNY's ROE of +0.12%. Regarding short-term risk, BTSG is less volatile compared to PGNY. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs CERT Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, CERT has a market cap of 1.9B. Regarding current trading prices, BTSG is priced at $23.67, while CERT trades at $11.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas CERT's P/E ratio is -573.25. In terms of profitability, BTSG's ROE is +0.03%, compared to CERT's ROE of -0.00%. Regarding short-term risk, BTSG is less volatile compared to CERT. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs SDGR Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SDGR has a market cap of 1.7B. Regarding current trading prices, BTSG is priced at $23.67, while SDGR trades at $22.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SDGR's P/E ratio is -8.71. In terms of profitability, BTSG's ROE is +0.03%, compared to SDGR's ROE of -0.45%. Regarding short-term risk, BTSG is less volatile compared to SDGR. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs NXGN Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, BTSG is priced at $23.67, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas NXGN's P/E ratio is -266.00. In terms of profitability, BTSG's ROE is +0.03%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, BTSG is more volatile compared to NXGN. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs PHR Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, PHR has a market cap of 1.5B. Regarding current trading prices, BTSG is priced at $23.67, while PHR trades at $25.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas PHR's P/E ratio is -34.84. In terms of profitability, BTSG's ROE is +0.03%, compared to PHR's ROE of -0.23%. Regarding short-term risk, BTSG is less volatile compared to PHR. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs OMCL Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, OMCL has a market cap of 1.5B. Regarding current trading prices, BTSG is priced at $23.67, while OMCL trades at $31.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas OMCL's P/E ratio is 67.43. In terms of profitability, BTSG's ROE is +0.03%, compared to OMCL's ROE of +0.02%. Regarding short-term risk, BTSG is less volatile compared to OMCL. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs GDRX Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, GDRX has a market cap of 1.4B. Regarding current trading prices, BTSG is priced at $23.67, while GDRX trades at $3.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas GDRX's P/E ratio is 56.14. In terms of profitability, BTSG's ROE is +0.03%, compared to GDRX's ROE of +0.07%. Regarding short-term risk, BTSG is less volatile compared to GDRX. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs AGTI Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, BTSG is priced at $23.67, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas AGTI's P/E ratio is -71.79. In terms of profitability, BTSG's ROE is +0.03%, compared to AGTI's ROE of -0.01%. Regarding short-term risk, BTSG is more volatile compared to AGTI. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs TDOC Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, BTSG is priced at $23.67, while TDOC trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas TDOC's P/E ratio is -1.19. In terms of profitability, BTSG's ROE is +0.03%, compared to TDOC's ROE of -0.68%. Regarding short-term risk, BTSG is less volatile compared to TDOC. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs TXG Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, TXG has a market cap of 1.1B. Regarding current trading prices, BTSG is priced at $23.67, while TXG trades at $9.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas TXG's P/E ratio is -7.01. In terms of profitability, BTSG's ROE is +0.03%, compared to TXG's ROE of -0.22%. Regarding short-term risk, BTSG is less volatile compared to TXG. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs EVH Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, EVH has a market cap of 1B. Regarding current trading prices, BTSG is priced at $23.67, while EVH trades at $8.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas EVH's P/E ratio is -7.00. In terms of profitability, BTSG's ROE is +0.03%, compared to EVH's ROE of -0.11%. Regarding short-term risk, BTSG is less volatile compared to EVH. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs HSTM Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, HSTM has a market cap of 877M. Regarding current trading prices, BTSG is priced at $23.67, while HSTM trades at $28.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas HSTM's P/E ratio is 45.60. In terms of profitability, BTSG's ROE is +0.03%, compared to HSTM's ROE of +0.05%. Regarding short-term risk, BTSG is less volatile compared to HSTM. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs NUTX Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, NUTX has a market cap of 822.2M. Regarding current trading prices, BTSG is priced at $23.67, while NUTX trades at $148.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas NUTX's P/E ratio is 12.00. In terms of profitability, BTSG's ROE is +0.03%, compared to NUTX's ROE of +0.71%. Regarding short-term risk, BTSG is less volatile compared to NUTX. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs MPLN-WT Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, BTSG is priced at $23.67, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to MPLN-WT's ROE of -5.18%. Regarding short-term risk, BTSG is less volatile compared to MPLN-WT. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs CTEV Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, CTEV has a market cap of 618M. Regarding current trading prices, BTSG is priced at $23.67, while CTEV trades at $37.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas CTEV's P/E ratio is -0.52. In terms of profitability, BTSG's ROE is +0.03%, compared to CTEV's ROE of -5.18%. Regarding short-term risk, BTSG is less volatile compared to CTEV. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs ACCD Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, BTSG is priced at $23.67, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas ACCD's P/E ratio is -3.08. In terms of profitability, BTSG's ROE is +0.03%, compared to ACCD's ROE of -0.45%. Regarding short-term risk, BTSG is more volatile compared to ACCD. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs CCLDP Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, CCLDP has a market cap of 566.6M. Regarding current trading prices, BTSG is priced at $23.67, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas CCLDP's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to CCLDP's ROE of +0.21%. Regarding short-term risk, BTSG is more volatile compared to CCLDP. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs SLP Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SLP has a market cap of 563.9M. Regarding current trading prices, BTSG is priced at $23.67, while SLP trades at $28.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SLP's P/E ratio is 77.89. In terms of profitability, BTSG's ROE is +0.03%, compared to SLP's ROE of +0.04%. Regarding short-term risk, BTSG is less volatile compared to SLP. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs SHCR Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, BTSG is priced at $23.67, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SHCR's P/E ratio is -3.76. In terms of profitability, BTSG's ROE is +0.03%, compared to SHCR's ROE of -0.24%. Regarding short-term risk, BTSG is more volatile compared to SHCR. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs SLGC Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, BTSG is priced at $23.67, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SLGC's P/E ratio is -3.04. In terms of profitability, BTSG's ROE is +0.03%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, BTSG is less volatile compared to SLGC. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs SLGCW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, BTSG is priced at $23.67, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, BTSG's ROE is +0.03%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, BTSG is less volatile compared to SLGCW. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs MPLN Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, BTSG is priced at $23.67, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas MPLN's P/E ratio is -0.23. In terms of profitability, BTSG's ROE is +0.03%, compared to MPLN's ROE of -5.18%. Regarding short-term risk, BTSG is less volatile compared to MPLN. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs DH Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, DH has a market cap of 374.6M. Regarding current trading prices, BTSG is priced at $23.67, while DH trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas DH's P/E ratio is -0.79. In terms of profitability, BTSG's ROE is +0.03%, compared to DH's ROE of -1.07%. Regarding short-term risk, BTSG is less volatile compared to DH. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs TBRG Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, TBRG has a market cap of 357.7M. Regarding current trading prices, BTSG is priced at $23.67, while TBRG trades at $23.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas TBRG's P/E ratio is -19.52. In terms of profitability, BTSG's ROE is +0.03%, compared to TBRG's ROE of -0.10%. Regarding short-term risk, BTSG is more volatile compared to TBRG. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs SPOK Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SPOK has a market cap of 330.6M. Regarding current trading prices, BTSG is priced at $23.67, while SPOK trades at $16.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SPOK's P/E ratio is 20.87. In terms of profitability, BTSG's ROE is +0.03%, compared to SPOK's ROE of +0.10%. Regarding short-term risk, BTSG is more volatile compared to SPOK. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs NRC Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, NRC has a market cap of 321.7M. Regarding current trading prices, BTSG is priced at $23.67, while NRC trades at $14.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas NRC's P/E ratio is 13.84. In terms of profitability, BTSG's ROE is +0.03%, compared to NRC's ROE of +0.71%. Regarding short-term risk, BTSG is less volatile compared to NRC. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs TRHC Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, BTSG is priced at $23.67, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas TRHC's P/E ratio is -4.27. In terms of profitability, BTSG's ROE is +0.03%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, BTSG is more volatile compared to TRHC. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs HCAT Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, HCAT has a market cap of 281.2M. Regarding current trading prices, BTSG is priced at $23.67, while HCAT trades at $4.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas HCAT's P/E ratio is -3.51. In terms of profitability, BTSG's ROE is +0.03%, compared to HCAT's ROE of -0.20%. Regarding short-term risk, BTSG is less volatile compared to HCAT. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs SMFR Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, BTSG is priced at $23.67, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SMFR's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to SMFR's ROE of -0.17%. Regarding short-term risk, BTSG is less volatile compared to SMFR. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs OPRX Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, OPRX has a market cap of 244.5M. Regarding current trading prices, BTSG is priced at $23.67, while OPRX trades at $13.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas OPRX's P/E ratio is -15.74. In terms of profitability, BTSG's ROE is +0.03%, compared to OPRX's ROE of -0.13%. Regarding short-term risk, BTSG is less volatile compared to OPRX. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs SOPH Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SOPH has a market cap of 201.2M. Regarding current trading prices, BTSG is priced at $23.67, while SOPH trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SOPH's P/E ratio is -3.01. In terms of profitability, BTSG's ROE is +0.03%, compared to SOPH's ROE of -0.63%. Regarding short-term risk, BTSG is less volatile compared to SOPH. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs CPSI Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, BTSG is priced at $23.67, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas CPSI's P/E ratio is -183.80. In terms of profitability, BTSG's ROE is +0.03%, compared to CPSI's ROE of -0.18%. Regarding short-term risk, BTSG is less volatile compared to CPSI. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs EUDA Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, EUDA has a market cap of 123.4M. Regarding current trading prices, BTSG is priced at $23.67, while EUDA trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas EUDA's P/E ratio is -6.15. In terms of profitability, BTSG's ROE is +0.03%, compared to EUDA's ROE of +3.05%. Regarding short-term risk, BTSG is less volatile compared to EUDA. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs SY Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SY has a market cap of 117.2M. Regarding current trading prices, BTSG is priced at $23.67, while SY trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SY's P/E ratio is -1.11. In terms of profitability, BTSG's ROE is +0.03%, compared to SY's ROE of -0.26%. Regarding short-term risk, BTSG is less volatile compared to SY. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs AUGX Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, BTSG is priced at $23.67, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas AUGX's P/E ratio is -4.99. In terms of profitability, BTSG's ROE is +0.03%, compared to AUGX's ROE of -1.13%. Regarding short-term risk, BTSG is more volatile compared to AUGX. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs AMWL Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, AMWL has a market cap of 109.9M. Regarding current trading prices, BTSG is priced at $23.67, while AMWL trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas AMWL's P/E ratio is -0.69. In terms of profitability, BTSG's ROE is +0.03%, compared to AMWL's ROE of -0.48%. Regarding short-term risk, BTSG is less volatile compared to AMWL. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs CCLD Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, CCLD has a market cap of 91.8M. Regarding current trading prices, BTSG is priced at $23.67, while CCLD trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas CCLD's P/E ratio is -9.86. In terms of profitability, BTSG's ROE is +0.03%, compared to CCLD's ROE of +0.21%. Regarding short-term risk, BTSG is less volatile compared to CCLD. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs CCLDO Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, CCLDO has a market cap of 85.3M. Regarding current trading prices, BTSG is priced at $23.67, while CCLDO trades at $19.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas CCLDO's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to CCLDO's ROE of +0.21%. Regarding short-term risk, BTSG is more volatile compared to CCLDO. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs FORA Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, FORA has a market cap of 64.3M. Regarding current trading prices, BTSG is priced at $23.67, while FORA trades at $2.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas FORA's P/E ratio is -17.17. In terms of profitability, BTSG's ROE is +0.03%, compared to FORA's ROE of -0.13%. Regarding short-term risk, BTSG is less volatile compared to FORA. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs BEAT Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, BEAT has a market cap of 60.9M. Regarding current trading prices, BTSG is priced at $23.67, while BEAT trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas BEAT's P/E ratio is -2.43. In terms of profitability, BTSG's ROE is +0.03%, compared to BEAT's ROE of -3.58%. Regarding short-term risk, BTSG is less volatile compared to BEAT. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs BEATW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, BEATW has a market cap of 48.5M. Regarding current trading prices, BTSG is priced at $23.67, while BEATW trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas BEATW's P/E ratio is -1.01. In terms of profitability, BTSG's ROE is +0.03%, compared to BEATW's ROE of -3.58%. Regarding short-term risk, BTSG is less volatile compared to BEATW. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs SNCE Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, BTSG is priced at $23.67, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SNCE's P/E ratio is -0.27. In terms of profitability, BTSG's ROE is +0.03%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, BTSG is more volatile compared to SNCE. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs AKLI Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, BTSG is priced at $23.67, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas AKLI's P/E ratio is -0.71. In terms of profitability, BTSG's ROE is +0.03%, compared to AKLI's ROE of -0.38%. Regarding short-term risk, BTSG is more volatile compared to AKLI. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs SHLT Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, BTSG is priced at $23.67, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SHLT's P/E ratio is -3.87. In terms of profitability, BTSG's ROE is +0.03%, compared to SHLT's ROE of -0.09%. Regarding short-term risk, BTSG is more volatile compared to SHLT. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs SHCRW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, BTSG is priced at $23.67, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, BTSG's ROE is +0.03%, compared to SHCRW's ROE of -0.24%. Regarding short-term risk, BTSG is less volatile compared to SHCRW. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs MGRX Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, MGRX has a market cap of 23.2M. Regarding current trading prices, BTSG is priced at $23.67, while MGRX trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas MGRX's P/E ratio is -0.45. In terms of profitability, BTSG's ROE is +0.03%, compared to MGRX's ROE of -0.73%. Regarding short-term risk, BTSG is less volatile compared to MGRX. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs RNLX Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, BTSG is priced at $23.67, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas RNLX's P/E ratio is -0.33. In terms of profitability, BTSG's ROE is +0.03%, compared to RNLX's ROE of +2.93%. Regarding short-term risk, BTSG is less volatile compared to RNLX. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs STRM Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, STRM has a market cap of 22.5M. Regarding current trading prices, BTSG is priced at $23.67, while STRM trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas STRM's P/E ratio is -2.05. In terms of profitability, BTSG's ROE is +0.03%, compared to STRM's ROE of -0.68%. Regarding short-term risk, BTSG is more volatile compared to STRM. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs LIFW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, BTSG is priced at $23.67, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas LIFW's P/E ratio is -0.02. In terms of profitability, BTSG's ROE is +0.03%, compared to LIFW's ROE of -3.08%. Regarding short-term risk, BTSG is more volatile compared to LIFW. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs VSEEW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, VSEEW has a market cap of 19.7M. Regarding current trading prices, BTSG is priced at $23.67, while VSEEW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas VSEEW's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to VSEEW's ROE of -6.10%. Regarding short-term risk, BTSG is more volatile compared to VSEEW. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs VSEE Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, VSEE has a market cap of 17.7M. Regarding current trading prices, BTSG is priced at $23.67, while VSEE trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas VSEE's P/E ratio is -11.30. In terms of profitability, BTSG's ROE is +0.03%, compared to VSEE's ROE of -6.10%. Regarding short-term risk, BTSG is less volatile compared to VSEE. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs BFRG Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, BFRG has a market cap of 16.1M. Regarding current trading prices, BTSG is priced at $23.67, while BFRG trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas BFRG's P/E ratio is -2.14. In terms of profitability, BTSG's ROE is +0.03%, compared to BFRG's ROE of -1.63%. Regarding short-term risk, BTSG is less volatile compared to BFRG. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs BBLN Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, BTSG is priced at $23.67, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas BBLN's P/E ratio is -0.04. In terms of profitability, BTSG's ROE is +0.03%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, BTSG is less volatile compared to BBLN. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs INOV Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, INOV has a market cap of 13.9M. Regarding current trading prices, BTSG is priced at $23.67, while INOV trades at $31.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas INOV's P/E ratio is 16.71. In terms of profitability, BTSG's ROE is +0.03%, compared to INOV's ROE of +0.03%. Regarding short-term risk, BTSG is more volatile compared to INOV. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs ONMD Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, ONMD has a market cap of 11.3M. Regarding current trading prices, BTSG is priced at $23.67, while ONMD trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas ONMD's P/E ratio is -1.09. In terms of profitability, BTSG's ROE is +0.03%, compared to ONMD's ROE of +0.60%. Regarding short-term risk, BTSG is less volatile compared to ONMD. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs SCNX Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SCNX has a market cap of 11.1M. Regarding current trading prices, BTSG is priced at $23.67, while SCNX trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SCNX's P/E ratio is 1.28. In terms of profitability, BTSG's ROE is +0.03%, compared to SCNX's ROE of +0.19%. Regarding short-term risk, BTSG is less volatile compared to SCNX. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs MSPR Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, MSPR has a market cap of 10.8M. Regarding current trading prices, BTSG is priced at $23.67, while MSPR trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas MSPR's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to MSPR's ROE of -3.08%. Regarding short-term risk, BTSG is less volatile compared to MSPR. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs ETAO Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, BTSG is priced at $23.67, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas ETAO's P/E ratio is -0.01. In terms of profitability, BTSG's ROE is +0.03%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, BTSG is less volatile compared to ETAO. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs HLTH Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, BTSG is priced at $23.67, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas HLTH's P/E ratio is -0.02. In terms of profitability, BTSG's ROE is +0.03%, compared to HLTH's ROE of -0.88%. Regarding short-term risk, BTSG is less volatile compared to HLTH. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs OTRK Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, OTRK has a market cap of 6.5M. Regarding current trading prices, BTSG is priced at $23.67, while OTRK trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas OTRK's P/E ratio is -0.09. In terms of profitability, BTSG's ROE is +0.03%, compared to OTRK's ROE of -1.76%. Regarding short-term risk, BTSG is more volatile compared to OTRK. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs ZCMD Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, ZCMD has a market cap of 5.8M. Regarding current trading prices, BTSG is priced at $23.67, while ZCMD trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas ZCMD's P/E ratio is -9.33. In terms of profitability, BTSG's ROE is +0.03%, compared to ZCMD's ROE of -0.03%. Regarding short-term risk, BTSG is less volatile compared to ZCMD. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs EUDAW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, EUDAW has a market cap of 5.4M. Regarding current trading prices, BTSG is priced at $23.67, while EUDAW trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas EUDAW's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to EUDAW's ROE of +3.05%. Regarding short-term risk, BTSG is more volatile compared to EUDAW. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs UPH Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, BTSG is priced at $23.67, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas UPH's P/E ratio is -0.07. In terms of profitability, BTSG's ROE is +0.03%, compared to UPH's ROE of -1.05%. Regarding short-term risk, BTSG is less volatile compared to UPH. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs PEARW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, BTSG is priced at $23.67, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas PEARW's P/E ratio is -0.00. In terms of profitability, BTSG's ROE is +0.03%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, BTSG is less volatile compared to PEARW. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs PEAR Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, BTSG is priced at $23.67, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas PEAR's P/E ratio is -0.08. In terms of profitability, BTSG's ROE is +0.03%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, BTSG is less volatile compared to PEAR. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs ACON Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, ACON has a market cap of 3.8M. Regarding current trading prices, BTSG is priced at $23.67, while ACON trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas ACON's P/E ratio is -0.56. In terms of profitability, BTSG's ROE is +0.03%, compared to ACON's ROE of -1.27%. Regarding short-term risk, BTSG is less volatile compared to ACON. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs HCTI Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, HCTI has a market cap of 3M. Regarding current trading prices, BTSG is priced at $23.67, while HCTI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas HCTI's P/E ratio is -0.01. In terms of profitability, BTSG's ROE is +0.03%, compared to HCTI's ROE of +2.95%. Regarding short-term risk, BTSG is less volatile compared to HCTI. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs FOXO Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, FOXO has a market cap of 2.7M. Regarding current trading prices, BTSG is priced at $23.67, while FOXO trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas FOXO's P/E ratio is -0.06. In terms of profitability, BTSG's ROE is +0.03%, compared to FOXO's ROE of -0.01%. Regarding short-term risk, BTSG is less volatile compared to FOXO. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs WGSWW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, WGSWW has a market cap of 2M. Regarding current trading prices, BTSG is priced at $23.67, while WGSWW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas WGSWW's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to WGSWW's ROE of -0.17%. Regarding short-term risk, BTSG is less volatile compared to WGSWW. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs WORX Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, WORX has a market cap of 1.8M. Regarding current trading prices, BTSG is priced at $23.67, while WORX trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas WORX's P/E ratio is -0.56. In terms of profitability, BTSG's ROE is +0.03%, compared to WORX's ROE of -0.32%. Regarding short-term risk, BTSG is less volatile compared to WORX. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs CMAX Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, BTSG is priced at $23.67, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas CMAX's P/E ratio is -0.00. In terms of profitability, BTSG's ROE is +0.03%, compared to CMAX's ROE of +30.94%. Regarding short-term risk, BTSG is less volatile compared to CMAX. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs ICCT Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, ICCT has a market cap of 1.3M. Regarding current trading prices, BTSG is priced at $23.67, while ICCT trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas ICCT's P/E ratio is -0.01. In terms of profitability, BTSG's ROE is +0.03%, compared to ICCT's ROE of -14.51%. Regarding short-term risk, BTSG is less volatile compared to ICCT. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs LIFWZ Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, BTSG is priced at $23.67, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to LIFWZ's ROE of -3.08%. Regarding short-term risk, BTSG is more volatile compared to LIFWZ. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs OTRKP Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, OTRKP has a market cap of 1M. Regarding current trading prices, BTSG is priced at $23.67, while OTRKP trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas OTRKP's P/E ratio is -0.08. In terms of profitability, BTSG's ROE is +0.03%, compared to OTRKP's ROE of -1.76%. Regarding short-term risk, BTSG is more volatile compared to OTRKP. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs KERNW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, BTSG is priced at $23.67, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas KERNW's P/E ratio is -0.00. In terms of profitability, BTSG's ROE is +0.03%, compared to KERNW's ROE of -2.22%. Regarding short-term risk, BTSG is less volatile compared to KERNW. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs KERN Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, BTSG is priced at $23.67, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas KERN's P/E ratio is -0.01. In terms of profitability, BTSG's ROE is +0.03%, compared to KERN's ROE of -2.22%. Regarding short-term risk, BTSG is less volatile compared to KERN. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs MSPRZ Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, MSPRZ has a market cap of 72K. Regarding current trading prices, BTSG is priced at $23.67, while MSPRZ trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to MSPRZ's ROE of -3.08%. Regarding short-term risk, BTSG is more volatile compared to MSPRZ. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs LIFWW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, BTSG is priced at $23.67, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas LIFWW's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to LIFWW's ROE of -3.08%. Regarding short-term risk, BTSG is more volatile compared to LIFWW. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs CMAXW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, BTSG is priced at $23.67, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas CMAXW's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to CMAXW's ROE of +30.94%. Regarding short-term risk, BTSG is more volatile compared to CMAXW. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs ACONW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, ACONW has a market cap of 17.6K. Regarding current trading prices, BTSG is priced at $23.67, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas ACONW's P/E ratio is -0.01. In terms of profitability, BTSG's ROE is +0.03%, compared to ACONW's ROE of -1.27%. Regarding short-term risk, BTSG is less volatile compared to ACONW. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs MSPRW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, MSPRW has a market cap of 5.9K. Regarding current trading prices, BTSG is priced at $23.67, while MSPRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas MSPRW's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to MSPRW's ROE of -3.08%. Regarding short-term risk, BTSG is more volatile compared to MSPRW. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs UTRS Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, UTRS has a market cap of 888. Regarding current trading prices, BTSG is priced at $23.67, while UTRS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas UTRS's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to UTRS's ROE of -1.11%. Regarding short-term risk, BTSG is more volatile compared to UTRS. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs CHNGU Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, BTSG is priced at $23.67, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas CHNGU's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, BTSG is more volatile compared to CHNGU. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs CNVY Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, BTSG is priced at $23.67, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas CNVY's P/E ratio is -71.50. In terms of profitability, BTSG's ROE is +0.03%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, BTSG is more volatile compared to CNVY. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs CSLT Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, BTSG is priced at $23.67, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas CSLT's P/E ratio is -37.27. In terms of profitability, BTSG's ROE is +0.03%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, BTSG is more volatile compared to CSLT. This indicates potentially higher risk in terms of short-term price fluctuations for BTSG.
BTSG vs NH Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, NH has a market cap of 0. Regarding current trading prices, BTSG is priced at $23.67, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas NH's P/E ratio is -0.12. In terms of profitability, BTSG's ROE is +0.03%, compared to NH's ROE of +0.35%. Regarding short-term risk, BTSG is less volatile compared to NH. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.
BTSG vs SMFRW Comparison
BTSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTSG stands at 4.1B. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, BTSG is priced at $23.67, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTSG currently has a P/E ratio of 87.67, whereas SMFRW's P/E ratio is N/A. In terms of profitability, BTSG's ROE is +0.03%, compared to SMFRW's ROE of -0.17%. Regarding short-term risk, BTSG is less volatile compared to SMFRW. This indicates potentially lower risk in terms of short-term price fluctuations for BTSG.